Get the latest tech news

A Gene Editing Therapy Cut Cholesterol Levels by Half

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

None

Related news:

The missing-in-action second-half of the Ark animated TV series has reappeared! Oh, with a formal delay

Abu Dhabi’s Adnoc Uses AI to Reduce Unplanned Shutdowns by Half

AI layoffs to backfire: Half quietly rehired at lower pay